Endotoxin contamination is an underappreciated risk in peptide research. Most discussions focus on purity (is it the correct peptide?) while overlooking contamination (are there dangerous substances alongside it?). Understanding endotoxin importance is essential.
What are endotoxins:
Endotoxins are lipopolysaccharides (LPS) found in the outer membrane of gram-negative bacteria. When bacteria die during manufacturing or handling, these molecules are released. They are extremely stable — they survive autoclaving, most chemical sterilization methods, and standard filtration. Specific depyrogenation processes are required for removal.
Why they matter for injectable peptides:
When endotoxins enter the body via injection, they trigger an immune response. At low levels, this might manifest as mild fever, injection site redness, or general malaise. At higher levels, endotoxins can cause significant inflammatory cascades including fever, chills, hypotension, and in extreme cases, septic shock. The body's immune system responds aggressively because it interprets them as a bacterial invasion.
The acceptable limit:
The standard pharmaceutical limit for injectable products is less than 5 EU (endotoxin units) per kg of body weight per hour. For a 70kg person, that is 350 EU per dose as an upper bound. Most properly manufactured research peptides should be well below this threshold.
On a COA, look for: LAL (Limulus Amebocyte Lysate) test results, reported in EU/mg or EU/mL. A result of less than 1 EU/mg is good. Less than 0.5 EU/mg is excellent.
Why most peptide COAs don't include endotoxin testing:
It is an additional expense that many vendors skip. HPLC purity and mass spec are considered baseline tests. Endotoxin testing adds $50-100+ per batch to vendor costs. Many researchers do not know to request it, so there is no market pressure.
Should endotoxin-tested peptides be required:
For subcutaneous injection: the risk is lower than for intravenous injection, but endotoxins can still cause localized and systemic reactions. For any peptide being injected, endotoxin data is a meaningful safety indicator.
If a vendor provides endotoxin testing alongside HPLC and mass spec, it signals a higher level of quality commitment. It does not guarantee safety on its own, but it closes a gap that purity testing alone does not address.
Practical consideration:
If fever, unusual injection site reactions, or flu-like symptoms consistently occur after peptide injection that are not explained by the peptide's known side effects, endotoxin contamination should be considered. Switching vendors, comparing experiences, and considering independent testing are appropriate if the pattern persists.
